Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer

被引：0
|
作者：
Sergio Granados-Principal
Yi Liu
Maria L Guevara
Elvin Blanco
Dong Soon Choi
Wei Qian
Tejal Patel
Angel A Rodriguez
Joseph Cusimano
Heidi L Weiss
Hong Zhao
Melissa D Landis
Bhuvanesh Dave
Steven S Gross
Jenny C Chang
机构：
[1] Methodist Cancer Center,Department of Nanomedicine
[2] Houston Methodist Hospital,Department of Chemistry and Biochemistry
[3] Medical and Health Sciences College,Biostatistics Shared Resource Facility, Markey Cancer Center
[4] Monterrey Institute of Technology,Department of Systems Medicine and Bioengineering
[5] Houston Methodist Research Institute,undefined
[6] Arizona State University,undefined
[7] University of Kentucky,undefined
[8] Houston Methodist Research Institute,undefined
[9] Weill Cornell Medical College,undefined
来源：
Breast Cancer Research | / 17卷
关键词：
Docetaxel; Endoplasmic Reticulum Stress; Amlodipine; iNOS Expression; TNBC Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer
    Granados-Principal, Sergio
    Liu, Yi
    Guevara, Maria L.
    Blanco, Elvin
    Choi, Dong Soon
    Qian, Wei
    Patel, Tejal
    Rodriguez, Angel A.
    Cusimano, Joseph
    Weiss, Heidi L.
    Zhao, Hong
    Landis, Melissa D.
    Dave, Bhuvanesh
    Gross, Steven S.
    Chang, Jenny C.
    BREAST CANCER RESEARCH, 2015, 17
  • [2] Novel targeted therapy development in triple-negative breast cancer
    Ueno, Naoto T.
    ANNALS OF ONCOLOGY, 2021, 32 : S258 - S258
  • [3] Targeted tumour photoImmunotherapy against triple-negative breast cancer therapy
    Raju, V.
    Yasothamani, V.
    ANNALS OF ONCOLOGY, 2020, 31 : S1272 - S1272
  • [4] Triple-negative breast cancer and the potential for targeted therapy
    Jhan, Jing-Ru
    Andrechek, Eran R.
    PHARMACOGENOMICS, 2017, 18 (17) : 1595 - 1609
  • [5] Personalized targeted therapy in triple-negative breast cancer
    Ueno, Naoto T.
    ANNALS OF ONCOLOGY, 2015, 26 : 20 - 20
  • [6] Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer
    Fatima, Mahak
    Sheikh, Afsana
    Abourehab, Mohammed A. S.
    Kesharwani, Prashant
    PHARMACEUTICS, 2022, 14 (11)
  • [7] A NEW TARGETED THERAPY FOR THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
    Martin, Janet L.
    de Silva, Hasanthi C.
    Scott, Carolyn D.
    Baxter, Robert C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 13 - 13
  • [8] Targeted therapy for triple-negative breast cancer: Where are we?
    Duffy, Michael J.
    McGowan, Patricia M.
    Crown, John
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (11) : 2471 - 2477
  • [9] Updates on Targeted Therapy for Triple-Negative Breast Cancer (TNBC)
    Noor Z.S.
    Master A.
    Current Breast Cancer Reports, 2018, 10 (4) : 282 - 288
  • [10] Triple-negative breast cancer: molecular subtypes and targeted therapy
    Hirshfield, Kim M.
    Ganesan, Shridar
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (01) : 34 - 40
12345